window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medical devices

  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Revita maintains GLP-1 weight loss one year after treatment discontinuation in REMAIN-1 trial

    Fractyl Health has reported positive one-year data from the midpoint [...]

    July 16, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Tenpoint submits UK application for presbyopia eye drop YUVEZZI

    Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

    July 14, 2026
  • Medical devices,Research & Development

    Organic semiconductor breakthrough could improve wearable healthcare sensors

    Researchers have developed a new way to precisely control organic [...]

    July 13, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Medical devices,Research & Development

    En Carta Diagnostics secures €5M to advance at-home molecular testing

    En Carta Diagnostics has raised €5 million to support regulatory [...]

    July 13, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Therapeutic Areas

    Theranica expands Nerivio migraine device coverage to more than half of insured Americans

    Theranica’s Nerivio wearable migraine therapy is now covered by health [...]

    July 13, 2026
  • Digital & Data,Medical devices,Research & Development

    Seegene launches global million-patient study of syndromic PCR testing

    Seegene has launched a global clinical study involving one million [...]

    July 9, 2026
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    Alamar launches blood-based eMTBR-Tau assay for Alzheimer’s disease research

    Alamar Biosciences has launched what it describes as the first [...]

    July 8, 2026
  • Advanced Therapies,Manufacturing & Supply Chain,Medical devices,Research & Development

    Bio-Rad launches Vericheck ddPCR kits for cell and gene therapy quality control

    Bio-Rad Laboratories has launched a portfolio of Vericheck ddPCR kits [...]

    July 8, 2026
  • Clinical & Regulatory,Medical devices

    Xeltis completes first commercial implant of aXess haemodialysis device

    Xeltis has completed the first commercial implantation of its aXess [...]

    July 7, 2026
  • Clinical & Regulatory,Medical devices,Research & Development

    Xeltis passes halfway mark in US trial of haemodialysis vascular access device

    Xeltis has passed the halfway enrolment mark in its US [...]

    July 3, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Eleva separates biologics platform from Factor H therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Pharmaceuticals and therapeutics, Research & Development
  • ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top